Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis

Summary

Voriconazole Inhalation Powder is available on an expanded access basis to patients with pulmonary aspergillosis for up to 12 weeks. Duration of treatment may be extended on a case-by-case basis depending on drug availability and after discussion with the Sponsor.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications